New Zealand markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.93-0.67 (-1.44%)
At close: 04:00PM EDT
45.93 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 115.77B
Enterprise value 125.90B
Trailing P/E 19.92
Forward P/E 11.14
PEG ratio (5-yr expected) 0.84
Price/sales (ttm)2.32
Price/book (mrq)1.44
Enterprise value/revenue 2.71
Enterprise value/EBITDA 9.99

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-17.84%
S&P500 52-week change 323.42%
52-week high 357.82
52-week low 342.63
50-day moving average 347.62
200-day moving average 350.26

Share statistics

Avg vol (3-month) 31.87M
Avg vol (10-day) 31.77M
Shares outstanding 52.5B
Implied shares outstanding 62.53B
Float 81.1B
% held by insiders 10.00%
% held by institutions 19.94%
Shares short (28 Mar 2024) 44.59M
Short ratio (28 Mar 2024) 42.34
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.16%
Shares short (prior month 29 Feb 2024) 44.31M

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 44.43%
Trailing annual dividend rate 33.76
Trailing annual dividend yield 38.07%
5-year average dividend yield 43.72
Payout ratio 482.36%
Dividend date 323 Jun 2023
Ex-dividend date 409 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 11.73%
Operating margin (ttm)6.91%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)7.27%

Income statement

Revenue (ttm)46.03B
Revenue per share (ttm)18.39
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)5.4B
Diluted EPS (ttm)2.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.71B
Total cash per share (mrq)6.98
Total debt (mrq)18.42B
Total debt/equity (mrq)24.78%
Current ratio (mrq)1.27
Book value per share (mrq)59.17

Cash flow statement

Operating cash flow (ttm)10.26B
Levered free cash flow (ttm)8.19B